ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
EMA PROVIDES KEY PATH TOWARD PHASE 3 TRIALS AND REGISTRATION
Published: 28/09/20, 08:53am (AEST)•3 pages